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Introduction {#sec001}
============

Dopamine is commonly regarded as the modulatory neurotransmitter underlying phenomenological experiences such as pleasure and joy. This "hedonic" impression derives from classic empirical approaches emphasizing the role of dopamine in the anticipation and seeking of rewarding outcomes \[[@pbio.3000744.ref001]--[@pbio.3000744.ref003]\]. Indeed, mounting evidence supports that dopamine regulates movement, motivation, and learning by tracking the violations of our reward expectations, which are encoded as reward prediction errors (PEs) \[[@pbio.3000744.ref004]--[@pbio.3000744.ref006]\]. Whereas sensory PEs report the surprise of unexpected sensory inputs in absolute magnitudes, reward PEs indicate whether outcomes were better or worse than expected, resulting in positively and negatively signed PEs, respectively \[[@pbio.3000744.ref007]\]. As a rule of thumb, dopaminergic neurons report positive PE values by increasing their phasic firing of action potentials and negative PE values by reducing their tonic discharge rates \[[@pbio.3000744.ref004]--[@pbio.3000744.ref006]\]. Hence, these dopaminergic neurons seem to signal a motivational ambivalence that guides adaptative motor, learning, and decision-making processes.

But some experimental evidence defies this classic understanding of dopamine. Aversive outcomes and cues that predict them can elicit dopaminergic activity \[[@pbio.3000744.ref008]--[@pbio.3000744.ref012]\], as well as events in which the reward PE should theoretically be zero, such as unexpected or surprising stimuli \[[@pbio.3000744.ref012]--[@pbio.3000744.ref018]\]. These dopaminergic responses seem to report sensory stimuli that may have behavioral relevance and should trigger an appropriate coordinated response, thus encoding perceptual salience without any positive or negative value.

The existence of signed and unsigned PEs is not mutually exclusive, and nowadays, there is relative consensus that dopamine participates in the attribution of physical and surprise salience to sensory stimuli (for a recent and comprehensive review, please refer to \[[@pbio.3000744.ref019]\]). Some authors suggest that novel and physically salient stimuli might be inherently rewarding, as they provide new information, which could be of value for adaptive behavior \[[@pbio.3000744.ref020],[@pbio.3000744.ref021]\]. Other works postulate a dual dopaminergic signaling, which respectively reports surprise and hedonic value in parallel \[[@pbio.3000744.ref022],[@pbio.3000744.ref023]\]. But proposals from the predictive processing framework advocate for a more integrative account of dopaminergic function, not necessarily bound to reward processing \[[@pbio.3000744.ref024],[@pbio.3000744.ref025]\].

The predictive coding framework comprises biologically informed Bayesian models based on early cybernetic theories, which regard the brain as a predictive Helmholtz machine \[[@pbio.3000744.ref026]--[@pbio.3000744.ref028]\]. Because we cannot directly access the "true" external world, but only its impression in our sensorium, the brain must infer the cause of those sensations. The brain generates expectations about the "hidden" states of the world by means of a hierarchical generative model, in which higher neural populations try to explain away (i.e., predict and inhibit) input from lower neural populations, and the resulting PE is used to update prior beliefs (i.e., learning). At each processing level, excitatory neurons receive excitatory input conveying bottom-up sensory evidence, as well as inhibitory input conveying top-down expectations. When these 2 inputs are congruent, their postsynaptic potentials cancel out; but when they are incongruent, a PE is generated to report the mismatch \[[@pbio.3000744.ref029]--[@pbio.3000744.ref033]\].

This unsigned PE accounts for both perception and learning, so the predictive processing framework can smoothly accommodate dopaminergic responses elicited by surprise. Behavior is optimal, not when reward (positive PE) is maximized, but when surprise (unsigned PE) is minimized, as this keeps the organism from potentially harmful interactions with the environment. Minimal PE is pursued via perceptual inference, i.e., improving the internal model of the world to better explain away incoming sensory input, and via active inference, i.e., changing sensory input by engaging in actions with predictable outcomes \[[@pbio.3000744.ref027],[@pbio.3000744.ref028]\]. Classic reinforcement learning tasks may have confused dopaminergic responses with reward PEs because of the more generic role that dopamine plays in PE minimization. Cues predicting rewards minimize PE by resolving the uncertainty about future outcomes, which is flagged by dopamine release \[[@pbio.3000744.ref024],[@pbio.3000744.ref025]\].

From the predictive processing standpoint, there are only 2 sorts of things that need to be inferred about the world: the state of the world and the uncertainty about that state \[[@pbio.3000744.ref024]\]. Beliefs about the hidden states of the world emerge from the hierarchical exchange of top-down predictions and bottom-up PEs, embodied in the synaptic activity of the nervous system. But every inferential process entails a certain degree of uncertainty due to, e.g., our sensory limitations, ambiguity, noise, or volatility in the probabilistic structure of the environment. Such uncertainty is accounted for in terms of posterior confidence or expected precision by means of the postsynaptic gain. Hence, synaptic messages are weighted according to their expected precision as they are passed along the processing hierarchy. When expected precision is high, PE signals are deemed reliable and receive postsynaptic amplification to strengthen their updating power. Conversely, when low precision is expected, PE signals undergo attenuation to prevent misrepresentations, and the influence of prior beliefs becomes prominent. In plain words, the expected precision is the postsynaptic gain that scales PE to modulate its influence on higher processing levels, such that more is learned from precise PEs than from noisy and unreliable PEs \[[@pbio.3000744.ref033]\].

Neuromodulators, such as dopamine, cannot directly excite or inhibit postsynaptic responses but only weight the postsynaptic responses to other neurotransmitters, acting as a gain control mechanism. Therefore, the only possible function of the dopaminergic system is to encode the expected precision \[[@pbio.3000744.ref024],[@pbio.3000744.ref025]\], playing a role in both perceptual and active inference by conferring contextual flexibility to both sensory and motor processing. Dopamine influence in motor processing and its function in active inference have received considerable scientific attention \[[@pbio.3000744.ref024],[@pbio.3000744.ref034]--[@pbio.3000744.ref037]\]. The same cannot be said about perceptual inference, maybe because of the relatively sparse and diffuse dopaminergic innervation of sensory structures. As a consequence of scarce empirical research, the physiological effects of dopamine on the processing of surprising sensory information are not well understood yet \[[@pbio.3000744.ref038]\].

The processing of surprising sensory information has been classically studied in humans using the auditory oddball paradigm \[[@pbio.3000744.ref039]\], in which the successive repetition of a tone ("standard condition" \[STD\]) is randomly interrupted by a surprising oddball tone ("deviant condition" \[DEV\]). When applied to animal models, the oddball paradigm unveils a phenomenon of neuronal short-term plasticity called stimulus-specific adaptation (SSA), measured as the difference between DEV and STD responses \[[@pbio.3000744.ref040]\]. SSA has been traditionally regarded as a rather mechanistical product of synaptic fatigue specifically affecting the transmission of the STD signal along the auditory system, while the processing channels conveying the infrequent DEV signal remained fresh \[[@pbio.3000744.ref041],[@pbio.3000744.ref042]\]. Nevertheless, the predictive processing framework has also reinterpreted the SSA observed in the auditory system \[[@pbio.3000744.ref043],[@pbio.3000744.ref044]\]. As higher neural populations explain away bottom-up sensory information, lower neural populations receiving their top-down predictions decrease responsiveness to expected sensory inputs, which, during an oddball paradigm, manifests functionally as SSA of the STD response. But when encountering DEV stimuli, predictions fail, forwarding PE signals to report the unexpected sensory input to the higher processing levels and update prior beliefs, thus generating a larger DEV response.

In a previous SSA study from our lab performed in awake and anaesthetized rodents, we demonstrated that DEV responses of auditory neurons from the midbrain, thalamus, and cortex were better explained as PE signaling activity \[[@pbio.3000744.ref045]\]. SSA first emerges in the auditory system at the level of the inferior colliculus (IC), mainly in its nonlemniscal portion (i.e., the IC cortices) \[[@pbio.3000744.ref046]\]. As a site of convergence of both ascending and descending auditory pathways, the IC plays a key role in processing surprising sounds \[[@pbio.3000744.ref047]\] and shaping the auditory context \[[@pbio.3000744.ref048]\]. The complex computational network of the IC integrates excitatory, inhibitory, and rich neuromodulatory input \[[@pbio.3000744.ref049],[@pbio.3000744.ref050]\], which includes dopaminergic innervation from the thalamic subparafascicular nucleus (SPF) \[[@pbio.3000744.ref051]--[@pbio.3000744.ref058]\]. Previous reports have detected mRNA coding for dopaminergic D~2~-like receptors in the IC \[[@pbio.3000744.ref057],[@pbio.3000744.ref058]\] and proved its functional expression as protein. Other studies have confirmed that dopamine modulates the auditory responses of IC neurons in heterogeneous manners \[[@pbio.3000744.ref052],[@pbio.3000744.ref059]\]. However, the involvement of dopaminergic modulation of SSA and sensory PE signaling in the IC is yet to be proven.

In order to test whether dopamine can modulate surprise responses and predictive sensory processing, we performed microiontophoretic injections of dopamine and eticlopride (a D~2~-like receptor antagonist) in the nonlemniscal IC while recording single and multiunit responses under oddball and regular auditory sequences. Our results demonstrate that dopamine has a profound effect on how unexpected sounds are processed, presumably encoding expected precision of sensory PEs at the level of the auditory midbrain.

Results {#sec002}
=======

In order to study the role of dopamine in shaping SSA and sensory PE signaling in the nonlemniscal IC, we recorded the auditory responses from a total of 142 single and multiunits in 31 young adult Long--Evans rats. In a first series of experiments, we presented the oddball paradigm before, during, and after microiontophoretic application of dopamine (*n* = 94) or eticlopride (*n* = 43). DEV and STD responses were used to calculate a common SSA index (CSI) for each unit and condition (see Protocol 1 in [Materials and methods](#sec012){ref-type="sec"}). In an additional series of experiments (*n* = 43, from the former pool of units), we also presented 2 predictable cascade sequences (CASs) in addition to the oddball paradigm, following the methodology of a previous study \[[@pbio.3000744.ref045]\]. In this subset, we measured SSA using the index of neuronal mismatch (iMM), which is calculated including DEV, STD, and CAS responses (see Protocol 2 in [Materials and methods](#sec012){ref-type="sec"}). Notwithstanding, both the iMM and the CSI are largely equivalent for indexing SSA \[[@pbio.3000744.ref045]\].

Histological verification located all recording sites in the rostral cortex of the IC ([Fig 1](#pbio.3000744.g001){ref-type="fig"}). This subdivision is part of the nonlemniscal IC, where SSA indices tend to be higher \[[@pbio.3000744.ref046],[@pbio.3000744.ref047],[@pbio.3000744.ref060]\].

![Histological location.\
(**A, B)** Coronal sections from 2 different animals showing electrolytic lesions (arrows) in the RCIC. Scale bar = 1 mm. Aq, aqueduct; CoIC, commissure of the inferior colliculus; M, medial; PAG, periaqueductal gray; RCIC, rostral cortex of the inferior colliculus; SC, superior colliculus; V, ventral.](pbio.3000744.g001){#pbio.3000744.g001}

Dopamine effects on the CSI {#sec003}
---------------------------

The microiontophoretic application of dopamine-induced changes in the firing rate (FR) and frequency response area (FRA) of the recorded units ([Fig 2](#pbio.3000744.g002){ref-type="fig"}). As a general consequence, SSA indices decreased by 15% in our sample, falling from a median CSI of 0.51 (0.25--0.78) in the control condition to 0.43 (0.15--0.73) after dopamine application (*p* = 0.014; [Fig 3A](#pbio.3000744.g003){ref-type="fig"}). Such SSA reduction was caused by a 26% drop in the median DEV response (control FR: 5.63 \[3.25--10.00\] spikes/s; dopamine FR: 4.19 \[1.63--7.63\]; *p* \< 0.001; red in [Fig 3B and 3C](#pbio.3000744.g003){ref-type="fig"}), whereas the STD response did not show a significant change (control FR: 1.71 \[0.64--3.83\]; dopamine FR: 1.63 \[0.36--3.65\]; *p* = 0.284; blue in [Fig 3B and 3D](#pbio.3000744.g003){ref-type="fig"}). As observed in previous reports \[[@pbio.3000744.ref046]\], the spontaneous firing rate (SFR) found in the nonlemniscal IC tended to be very scarce (for individual examples, see [Fig 3E and 3F](#pbio.3000744.g003){ref-type="fig"}) and did not change significantly with dopamine application (control SFR: 0.18 \[0.05--0.77\]; dopamine SFR: 0.15 \[0.03--0.90\]; *p* = 0.525; gray in [Fig 3B](#pbio.3000744.g003){ref-type="fig"}).

![Dopamine effects on the FRA.\
**(A)** FRA of a neuron in control condition (left panel) and after dopamine application (right panel). **(B)** The subtraction of the control FRA from the FRA after dopamine application reveals that dopamine increased the excitability of this unit. **(C)** FRA of another neuron in control condition (left panel) and after dopamine application (right panel). **(D)** The subtraction of the control FRA from that after dopamine application in **(C)** reveals that dopamine decreased the excitability of this neuron. The underlying data for this figure can be found in [S1 Data](#pbio.3000744.s001){ref-type="supplementary-material"}. dB SPL, decibels of sound pressure level; FRA, frequency response area](pbio.3000744.g002){#pbio.3000744.g002}

![Dopamine effects on the CSI.\
**(A)** Scatterplot of the CSI in control condition versus dopamine application. Units that underwent significant CSI changes are represented in purple, whereas the rest are marked as gray dots. The purple cross on the abscissa axis represents 1 CSI measurement in which ordinate value falls out of scale (*y* = −0.59). **(B)** Violin plots of the SFR (gray), DEV response (red), and STD response (blue). Control conditions are represented in the left half of each violin (no color), whereas dopamine effects are on display in the right half (colored). Horizontal thick black lines mark the median of each distribution, and vertical bars cover the interquartile range. Regarding statistical significance, n.s. indicates that *p* \> 0.05 and **\*\*\*** indicates that *p* \< 0.001. **(C)** Scatterplot of DEV responses in control condition versus dopamine application. **(D)** Scatterplot of STD responses in control condition versus dopamine application. **(E)** Peristimulus histogram of a unit before (left panel), during (middle panel), and after (right panel) dopamine application. In this case, dopamine reduced the CSI. **(F)** Another example showing the opposite effects. The underlying data for this Figure can be found in [S2 Data](#pbio.3000744.s002){ref-type="supplementary-material"}. CSI, common stimulus-specific adaptation index; DEV, deviant condition; FR, firing rate; SFR, spontaneous firing rate; STD, standard condition.](pbio.3000744.g003){#pbio.3000744.g003}

Previous studies had reported heterogeneous dopaminergic effects on the response of IC neurons \[[@pbio.3000744.ref052],[@pbio.3000744.ref059]\], so we performed a bootstrap analysis to evaluate the statistical significance of CSI changes unit by unit. We confirmed such heterogeneity across our sample, with 42 units following the population trend by decreasing their CSI, whereas 33 units showed CSI increments under dopamine; 19 units remained unaltered ([Fig 3A](#pbio.3000744.g003){ref-type="fig"}). [Fig 3E](#pbio.3000744.g003){ref-type="fig"} shows the response of a unit to STD (blue) and DEV (red) in the control condition (left panel), during dopamine application (middle panel), and after recovery (right panel). The application of dopamine caused an increment of the STD response and a decrement of the DEV response, leading to a decrease of the CSI. In contrast, the unit in [Fig 3F](#pbio.3000744.g003){ref-type="fig"} showed a decrement of the response to both STD and DEV during the application of dopamine, thus resulting in an increase of the CSI. The effects of dopamine peaked around 8--10 minutes after microiontophoretic application, followed by a progressive recovery to baseline values that could take beyond 90 minutes ([Fig 3E and 3F](#pbio.3000744.g003){ref-type="fig"}, right panels).

Eticlopride effects on the CSI {#sec004}
------------------------------

We aimed to determine whether dopaminergic effects on the CSI were mediated by D~2~-like receptors, as suggested by previous reports \[[@pbio.3000744.ref057],[@pbio.3000744.ref058]\]. To test endogenous dopaminergic modulation on SSA mediated by D~2~-like receptors, we applied eticlopride, a D~2~-like receptor antagonist, to 43 units. We observed no significant response changes at sample level (DEV FR: *p* = 0.609; STD FR: *p* = 0.769; SFR: *p* = 0.405; CSI change: *p* = 0.170; [Fig 4](#pbio.3000744.g004){ref-type="fig"}). However, we performed a bootstrap analysis to evaluate the statistical significance of CSI changes in each unit under eticlopride influence, which revealed that only 11 units remained unaffected ([Fig 4A](#pbio.3000744.g004){ref-type="fig"}). The CSI had significantly decreased in 13 units (see individual example in [Fig 4E](#pbio.3000744.g004){ref-type="fig"}) and increased in 19 units (see individual example in [Fig 4F](#pbio.3000744.g004){ref-type="fig"}), implying that eticlopride was indeed antagonizing endogenous dopaminergic modulation mediated by D~2~-like receptors on those units.

![Eticlopride effects on the CSI.\
**(A)** Scatterplot of the CSI in control condition versus eticlopride application. Units that underwent significant CSI changes are represented in green, whereas the rest are marked as gray dots. **B.** Violin plots of the SFR (gray), DEV response (red), and STD response (blue). Control conditions are represented in the left half of each violin (no color), whereas eticlopride effects are on display in the right half (colored). Horizontal thick black lines mark the median of each distribution, and vertical bars cover the interquartile range. Regarding statistical significance, n.s. indicates that *p* \> 0.05. **(C)** Scatterplot of DEV responses in control condition versus eticlopride application. **(D)** Scatterplot of STD responses in control condition versus eticlopride application. **(E)** Peristimulus histogram of a unit before (left panel), during (middle panel), and after (right panel) eticlopride application. In this case, eticlopride reduced the CSI. **(F)** Another unit example showing the opposite effects. The underlying data for this figure can be found in [S3 Data](#pbio.3000744.s003){ref-type="supplementary-material"}. CSI, common stimulus-specific adaptation index; DEV, deviant condition; FR, firing rate; SFR, spontaneous firing rate; STD, standard condition.](pbio.3000744.g004){#pbio.3000744.g004}

Dopamine effects on unexpected auditory input {#sec005}
---------------------------------------------

To test whether dopamine modulates sensory PE signaling in the nonlemniscal IC, we performed an additional set of experiments (see Protocol 2 in [Materials and methods](#sec012){ref-type="sec"}) adapting our methodology to that of a previous study \[[@pbio.3000744.ref045]\]. Alongside the oddball paradigm ([Fig 5A](#pbio.3000744.g005){ref-type="fig"}), we recorded responses of 43 units to 2 CAS conditions, which consisted of a sequence of 10 tones presented in a predictable succession of increasing or decreasing frequencies ([Fig 5B](#pbio.3000744.g005){ref-type="fig"}).

![Dopamine effects on unexpected auditory input.\
**(A)** Oddball paradigm, displaying 2 experimental conditions for a given *f*~*i*~ target tone. **(B)** CASs highlighting the *f*~*i*~ target tone. **(C)** Scatterplot of the iMM in control condition versus dopamine application. Frequencies that underwent significant iMM changes are represented in purple, whereas the rest are marked as gray dots. **(D)** Violin plots of the CAS (green), DEV (red), and STD (blue) normalized responses. Control conditions are represented in the left half of each violin (no color), and dopamine effects are on display in the right half (colored). Horizontal thick black lines mark the median of each distribution, and the boxplots inside each distribution indicate the interquartile range, with the confidence interval for the median indicated by the notches. Regarding statistical significance, n.s. indicates that *p* \> 0.05, and **\*\*** indicates that *p* \< 0.01 (repeated-measures ANOVA, Dunn--Šidák correction). The underlying data for this figure can be found in [S4 Data](#pbio.3000744.s004){ref-type="supplementary-material"}. CAS, cascade sequence; DEV, deviant condition; FR, firing rate; iMM, index of neuronal mismatch; SFR, spontaneous firing rate; STD, standard condition.](pbio.3000744.g005){#pbio.3000744.g005}

We used a bootstrap analysis to evaluate the statistical significance of the effect of dopamine on the iMM of each recording, which confirmed that 23 units underwent heterogeneous iMM changes ([Fig 5C](#pbio.3000744.g005){ref-type="fig"}, colored dots, each representing one tested frequency), whereas another 18 remained stable ([Fig 5C](#pbio.3000744.g005){ref-type="fig"}, gray dots). Results agreed with those obtained using the CSI, as the iMM of the sample fell by 22%, from a median of 0.57 (0.41--0.69) in the control condition to a median of 0.45 (0.27--0.65) under dopaminergic influence (*p* = 0.002; [Fig 5C](#pbio.3000744.g005){ref-type="fig"}). This was caused by a significant reduction in the median DEV response (control normalized FR: 0.70 \[0.58--0.80\]; dopamine normalized FR: 0.64 \[0.47--0.78\]; *p* = 0.002), whereas the STD response was not affected (control normalized FR: 0.11 \[0.02--0.23\]; dopamine normalized FR: 0.10 \[0.03--0.31\]; *p* = 0.188). Most interestingly, CAS responses also remained unaffected by dopamine application (control normalized FR: 0.68 \[0.52--0.77\]; dopamine normalized FR: 0.71 \[0.57--0.83\]; *p* = 0.115; [Fig 5D](#pbio.3000744.g005){ref-type="fig"}).

Discussion {#sec006}
==========

We recorded single and multiunit activity in the nonlemniscal IC ([Fig 1](#pbio.3000744.g001){ref-type="fig"}) under an auditory oddball paradigm while performing microiontophoretic applications of dopamine and eticlopride (D~2~-like receptor antagonist). Following the discovery of PE signaling activity in the nonlemniscal IC \[[@pbio.3000744.ref045]\], we included CASs \[[@pbio.3000744.ref061]\] in a subset of experiments to address dopamine role from a predictive processing standpoint. This resulted in 3 stimulation conditions: (1) STD or expected repetition ([Fig 5A](#pbio.3000744.g005){ref-type="fig"}, bottom), susceptible of generating intense SSA; (2) DEV or unexpected change ([Fig 5A](#pbio.3000744.g005){ref-type="fig"}, top), which should be the most surprising and thus elicit the strongest PE signaling; and (3) CAS or expected change ([Fig 5B](#pbio.3000744.g005){ref-type="fig"}), a condition featuring the same STD-to-DEV step, but which neither undergo SSA (unlike STD) nor should entail a PE (or, at least, not as strong as DEV). Our results revealed that dopamine modulates surprise processing in the auditory midbrain.

Dopamine attenuates PE signaling from the auditory midbrain {#sec007}
-----------------------------------------------------------

Dopamine application caused a 15% reduction of SSA indices in the nonlemniscal IC (Figs [3A](#pbio.3000744.g003){ref-type="fig"} and [5C](#pbio.3000744.g005){ref-type="fig"}) because of a general drop in DEV responses of about 25% ([Fig 3B and 3C](#pbio.3000744.g003){ref-type="fig"}). Neither STD ([Fig 3B and 3D](#pbio.3000744.g003){ref-type="fig"}) nor CAS responses were significantly affected at population level ([Fig 5D](#pbio.3000744.g005){ref-type="fig"}). The differential effect of dopamine on DEV and STD cannot be explained by the differences in their control FRs, because CAS yielded FRs as high as DEV that were not similarly reduced by dopamine ([Fig 5D](#pbio.3000744.g005){ref-type="fig"}). In other words, dopamine application decreased the responsiveness to surprising stimuli, whereas the responsiveness to the expected stimuli remained stable. Therefore, dopaminergic action on the auditory neurons of the nonlemniscal IC exclusively modulates PE signaling.

Eticlopride effects did not describe significant tendencies at population level ([Fig 4](#pbio.3000744.g004){ref-type="fig"}). Nevertheless, about 75% of our sample manifested significant SSA changes under eticlopride ([Fig 4A](#pbio.3000744.g004){ref-type="fig"}, colored dots). This confirms the release of endogenous dopamine, as well as the functional expression of D~2~-like receptors in the nonlemniscal IC. Taken together with previous findings regarding dopaminergic modulation of the IC \[[@pbio.3000744.ref052],[@pbio.3000744.ref057]--[@pbio.3000744.ref059]\], the attenuation of PE signaling is most likely mediated by D~2~-like receptors.

The net attenuation of PE signaling from the auditory midbrain under dopamine influence is unique as compared with the effects of other neurotransmitters and neuromodulators on IC neurons. GABAergic and glutamatergic manipulations alter the general excitability of IC neurons, thereby exerting symmetrical effects on both STD and DEV responses \[[@pbio.3000744.ref062]--[@pbio.3000744.ref064]\]. Cholinergic and cannabinoid manipulation yield asymmetrical effects that mostly affect STD responses \[[@pbio.3000744.ref065],[@pbio.3000744.ref066]\]. Activation of M~1~ muscarinic receptors tend to reduce average SSA indices by increasing responsiveness to repetitive stimuli (i.e., STD) \[[@pbio.3000744.ref065]\]. Dopamine delivers asymmetrical effects that also tend to reduce average SSA indices. But the activation of D~2~-like receptors decreases the responsiveness to surprising stimuli (i.e., DEV). The complementary effects of dopaminergic and cholinergic modulation hint at a conjoint action of neuromodulatory systems in adjusting the bottom-up flow of sensory information form subcortical structures ([Fig 6](#pbio.3000744.g006){ref-type="fig"}).

![SPF auditory afferences.\
Schematic diagram of the main connections involved in SSA modulation and PE precision-weighting in the IC. The auditory pathway (in pink) is composed of ascending (solid arrows) and descending connections (dashed arrows) between cortical and subcortical auditory structures. The hierarchical exchange of bottom-up PEs and top-down predictions postulated by the predictive coding framework could be extended to subcortical auditory neurons by means of these feedback loops. The SPF (purple) receives input from main auditory nuclei (pink) and from the mPFC (violet), integrating information from manifold hierarchical processing levels. Such connectivity could allow SPF dopaminergic neurons to estimate the volatility of the probabilistic structure of the auditory context. In turn, the SPF sends dopaminergic projections back to the IC to signal the expected precision of PE signaling at low processing levels. Dopamine release in the nonlemnical IC reduces the postsynaptic responses to surprising stimuli (red) but has no effect on repetitive ones (blue), consequently reducing SSA indices. By contrast, cholinergic modulation from the LDT and PPT nuclei (brown) of the brainstem increases the responses to repetitive stimuli in the IC \[[@pbio.3000744.ref065]\]. Note that the net effect of both dopamine and acetylcholine is the reduction of SSA indices, decreasing the relative saliency of surprising input through complementary means. AC, auditory cortex; CAS, cascade sequence; IC, inferior colliculus; LDT, laterodorsal tegmental; MGB, medial geniculate body; mPFC, medial prefrontal cortex; PE, prediction error; PPT, pedunculopontine tegmental; SOC, superior olivary complex; SPF, subparafascicular nucleus of the thalamus; SSA, stimulus-specific adaptation.](pbio.3000744.g006){#pbio.3000744.g006}

Intrinsic and synaptic properties generate heterogeneous dopaminergic effects {#sec008}
-----------------------------------------------------------------------------

In line with previous reports \[[@pbio.3000744.ref052],[@pbio.3000744.ref059]\], we observed heterogeneous dopaminergic effects across units (see individual examples in Figs [1](#pbio.3000744.g001){ref-type="fig"}, [3E](#pbio.3000744.g003){ref-type="fig"}, [3F](#pbio.3000744.g003){ref-type="fig"}, [4E and 4F](#pbio.3000744.g004){ref-type="fig"}). Complex dopaminergic interactions altering the excitation--inhibition balance cannot be accurately tracked, because the exact location and neuronal types expressing D~2~-like receptors in the IC are yet to be determined. Notwithstanding, the heterogeneity of dopaminergic effects must result from distinctive intrinsic and synaptic properties.

D~2~-like receptors are coupled to G proteins, which regulate the activity of manifold voltage-gated ion channels, adjusting excitability depending on the repertoire expressed in each neuron \[[@pbio.3000744.ref067]\]. D~2~-like receptors coupled to G~i/o~ proteins can both increase potassium currents and decrease calcium currents via G~βγ~ subunit complex, thereby reducing excitability \[[@pbio.3000744.ref067]\]. The opening probability of calcium channels can also diminish by the activation of D~2~-like receptors coupled to G~q~ proteins \[[@pbio.3000744.ref067]\]. D~2~-like receptor activation can augment or reduce sodium currents depending on the receptor subtypes expressed on the neuronal membrane \[[@pbio.3000744.ref067]\]. Furthermore, D~2~-like receptor activation can also reduce N-methyl-D-aspartate (NMDA) synaptic transmission, decreasing the FR \[[@pbio.3000744.ref067]\]. In addition, nonlemniscal IC neurons express hyperpolarization-activated cyclic nucleotide-gated (HCN) channels \[[@pbio.3000744.ref068],[@pbio.3000744.ref069]\], which can be modulated by dopamine and yield mixed effects on neuronal excitability \[[@pbio.3000744.ref070]\].

On the other hand, dopamine and eticlopride can interact with D~2~-like receptors expressed in a presynaptic neuron. Both glutamatergic and GABAergic projections converge onto single IC neurons \[[@pbio.3000744.ref049],[@pbio.3000744.ref071],[@pbio.3000744.ref072]\], which may also receive dopaminergic inputs from the SPF \[[@pbio.3000744.ref051]--[@pbio.3000744.ref055],[@pbio.3000744.ref057]\]. Dopamine could potentially activate presynaptic D~2~-like receptors expressed in a excitatory neuron, as described in striatal medium spiny neurons \[[@pbio.3000744.ref073]--[@pbio.3000744.ref075]\], or conversely in a inhibitory neuron, as demonstrated in the ventral tegmental area \[[@pbio.3000744.ref076]\].

SPF dopaminergic projections to the IC could scale sensory PEs {#sec009}
--------------------------------------------------------------

Dopaminergic function has been traditionally studied in the context of reinforcement learning, in which dopamine is thought to report the discrepancies between expected and observed rewards in "reward PEs" \[[@pbio.3000744.ref002],[@pbio.3000744.ref003]\]. Dopaminergic neurons report positive PE values when reward expectations are exceeded by increasing their firing and negative PE values when reward expectations are not matched by reducing their tonic discharge rates, thereby guiding the learning process \[[@pbio.3000744.ref005],[@pbio.3000744.ref006]\]. Hence, these signed "reward PEs" encoded by dopaminergic neurons are substantially different from the unsigned "sensory PEs" encoded by auditory neurons in the nonlemniscal IC \[[@pbio.3000744.ref031]--[@pbio.3000744.ref033]\]. According to this classic interpretation of dopaminergic function, exogenous dopamine ejections in the nonlemniscal IC should mimic reinforcing signals coming from the SPF \[[@pbio.3000744.ref051]--[@pbio.3000744.ref055],[@pbio.3000744.ref057]\]. Speculatively, such dopaminergic input might aim to induce long-term potentiation on IC neurons to build lasting associations between acoustic cues and rewarding outcomes, thereby contributing to establish reward expectations. However, we fail to see why these dopaminergic PEs would mitigate the transmission of sensory PEs from the nonlemniscal IC, as evidenced by the reduced surprise responsiveness we have observed after dopamine application.

The recent interpretation from the predictive processing framework argues that information about the hidden states of the world (i.e., PEs) cannot be encoded by dopamine release, because dopamine cannot directly excite the postsynaptic responses, which would be needed to convey that information \[[@pbio.3000744.ref024]\]. Dopamine can only modulate the postsynaptic responses to other neurotransmitters, a function more compatible with expected precision encoding and PE weighting. This alternative approach spares the need of 2 distinct types of PE signaling while better accommodating some findings that were not easily explained as reward PEs \[[@pbio.3000744.ref024]\]. A significant portion of dopaminergic neurons increase their firing in response to aversive stimuli and cues that predict them, contrary to how reward PEs should work \[[@pbio.3000744.ref008]--[@pbio.3000744.ref012]\]. Most relevant to the present study, some dopaminergic neurons also respond to conditions in which the reward PE should theoretically be zero, including unexpected or surprising stimuli \[[@pbio.3000744.ref012]--[@pbio.3000744.ref018]\]. Therefore, we consider that the most suited way of interpreting our data is through the lens of a precision-weighting mechanism. Dopamine function in the auditory midbrain could be to account for the uncertainty about the probabilistic structure of the auditory context and scale sensory PEs accordingly.

The predictive processing framework describes a processing hierarchy in which PEs emitted by a lower-level system become the input for a higher-level system, whereas feedback from the higher-level system provides the expectations for the lower-level system \[[@pbio.3000744.ref029]--[@pbio.3000744.ref033]\]. Hence, not all the sensory input is conveyed bottom-up through the processing hierarchy but only the resultant PEs at each level, which, in turn, are progressively explained away level after level. Consequently, expectations in lower-level neural populations are rather overfitted, short-spanned, and prone to PE, whereas higher neural populations acquire greater integrative scope at the expense of accuracy. Thus, higher-order predictions are less specific but also provide more abstract and durable beliefs about the probabilistic structure of the environment and its volatility, which can be used to optimally adjust sensory processing at lower levels.

Nonlemniscal neurons on the IC cortices receive abundant ascending, descending, and neuromodulatory input through their large dendritic arbors \[[@pbio.3000744.ref050],[@pbio.3000744.ref055],[@pbio.3000744.ref077],[@pbio.3000744.ref078]\], which translate into wide auditory receptive fields ([Fig 2](#pbio.3000744.g002){ref-type="fig"}) capable of integrating frequency fluctuations in the time scale of seconds \[[@pbio.3000744.ref079]--[@pbio.3000744.ref081]\]. During an oddball sequence, the successive STD stimuli are readily explained away in nonlemniscal IC neurons \[[@pbio.3000744.ref045],[@pbio.3000744.ref046]\], most likely constituting one of the lowest processing levels in the auditory system of the hierarchical generative model \[[@pbio.3000744.ref043],[@pbio.3000744.ref044]\]. However, the low predictability of DEV stimuli would lead to some irreducible PE. The random 10% chance of getting a DEV stimulus adds uncertainty to the expectation of a STD repetition, and such uncertainty must be accounted for in order to minimize this otherwise irreducible PE during perceptual inference. Higher-order auditory processing levels are endowed with larger timescales of integration and only receive the bottom-up PEs reporting the rare and aleatory appearances of DEV stimuli. Hence, the probabilistic structure of the oddball paradigm and its volatility could be encoded at higher auditory stations, which may, in turn, backward signal the expected precision at lower processing levels by means of neuromodulation. Thus, as hierarchically higher processing levels somewhat foresee and top-down communicate the stochastic 10% possibility of failing in the STD prediction, the appearance of a DEV stimulus in the middle of a train of STD stimuli will not be as surprising, thus attenuating PE signaling.

Following this rationale, dopamine release in the auditory midbrain would modulate the postsynaptic transmission of surprising sensory information by encoding uncertainty in the auditory context. As a result, the otherwise irreducible PE prompted by oddball stimuli can be minimized from a rather early stage of auditory processing. In natural conditions, such midbrain-level scaling of PEs could be performed by SPF dopaminergic neurons projecting to the IC \[[@pbio.3000744.ref051]--[@pbio.3000744.ref058]\]. Both glutamatergic and GABAergic neurons in the nonlemniscal IC receive comparable dopaminergic innervation from the SPF \[[@pbio.3000744.ref055]\]. Thereby the SPF could finely modulate the postsynaptic gain of both excitatory and inhibitory activity in the auditory midbrain. This top-down adjustment of expected precision would be done in conjuncture with other neuromodulatory systems; e.g., cholinergic projections synapse with glutamatergic neurons in the nonlemniscal IC \[[@pbio.3000744.ref055]\], yielding modulatory effects, which seem to complement those of dopamine \[[@pbio.3000744.ref065]\] ([Fig 6](#pbio.3000744.g006){ref-type="fig"}).

Many higher and lower nuclei project to the SPF, including the auditory cortex, auditory thalamus, the superior olivary complex, and the IC itself, thus providing the SPF with rich auditory information \[[@pbio.3000744.ref056],[@pbio.3000744.ref082]--[@pbio.3000744.ref085]\] ([Fig 6](#pbio.3000744.g006){ref-type="fig"}, in pink). Outside the auditory pathway, other centers performing higher-order functions in sensorimotor processing and integration also send projections to the SPF, such as the medial prefrontal cortex ([Fig 6](#pbio.3000744.g006){ref-type="fig"}, in blue) or the deep layers of the superior colliculus \[[@pbio.3000744.ref084]\]. The dopaminergic activity of the SPF must be interwoven to a great extent with the general functioning of the auditory system, thus enabling a potential role in perceptual inference. The reciprocal connectivity of the SPF with many nuclei at multiple levels of the auditory pathway and beyond could provide the neuroanatomical substrate for an early top-down modulation of expected precision, scaling PEs forwarded from the auditory midbrain through descending dopaminergic projections ([Fig 6](#pbio.3000744.g006){ref-type="fig"}, in purple).

Limitations {#sec010}
-----------

At first glance, our proposal might seem at odds with some previous works from the predictive processing framework regarding neuromodulation. Whereas cholinergic and NMDA manipulation are often reported to yield precision-weighting effects \[[@pbio.3000744.ref086]--[@pbio.3000744.ref088]\], dopaminergic effects on PE are less common in the literature \[[@pbio.3000744.ref089]\], and those are mostly linked to processes of active inference \[[@pbio.3000744.ref024],[@pbio.3000744.ref034]--[@pbio.3000744.ref037]\], rather than perceptual inference \[[@pbio.3000744.ref090]\]. Besides, classic neuromodulators are often thought to increase the expected precision of PE signaling \[[@pbio.3000744.ref086]\], contrary to the attenuating net effects of dopamine that we found in the nonlemniscal IC. Notwithstanding, it is important to keep in mind that the current view on the relationship between neuromodulation and expected precision derives from (and mainly refers to) cortical data. Cortical intrinsic circuitry and its neuromodulatory sources are vastly different to those of the nonlemniscal IC, so functional differences could be expected as well.

Cortical predictive processing implementations have proposed specific hypotheses about the neuronal types and mechanisms encoding precision-weighted PEs in a defined canonical microcircuit \[[@pbio.3000744.ref029],[@pbio.3000744.ref031],[@pbio.3000744.ref032]\]. Unfortunately, to the best of our knowledge \[[@pbio.3000744.ref047],[@pbio.3000744.ref049]\], current understanding on the intrinsic circuitry of the nonlemniscal IC does not allow for the direct import of such hypotheses into auditory midbrain processing or for us to be more specific about how this mechanism of PE scaling could be implemented ([Fig 6](#pbio.3000744.g006){ref-type="fig"}). The observed heterogeneity of dopaminergic effects in our sample, in addition to the fact that the SPF dopaminergic projections synapse with both glutamatergic and GABAergic neurons \[[@pbio.3000744.ref055]\], hints at distinct neuronal types fulfilling differentiated processing roles in the proposed precision-weighting mechanism of the nonlemniscal IC. However, it is not possible to distinguish between neuronal types and assign them putative roles solely based on their functional data \[[@pbio.3000744.ref091]\]. So far, not even the mechanisms underlying SSA in the auditory midbrain are clearly established. A recent study using in vivo whole-cell recordings in the IC found that excitatory and inhibitory inputs of SSA neurons did not differ significantly from other neurons not exhibiting SSA, and that synaptic adaptation could not be used to predict the presence of spiking SSA \[[@pbio.3000744.ref092]\].

Finally, microiontophoresis cannot reproduce the temporal and spatial aspects of natural dopamine release, mimicking the tonic and phasic firing of dopaminergic neurons. Applied dopamine may recruit receptors that are not normally activated by endogenous release. The discrepancy between our observed net effect of PE attenuation and the amplifying effect expected by predictive processing models could be caused by such technical limitation. In any case, this study confirms that dopamine can modulate unsigned PE attending to the probabilistic structure of sensory input. Furthermore, our results make room for distinct roles of neuromodulation along the multiple stages of predictive processing along the auditory hierarchy, a possibility that could be further addressed in future studies.

Conclusions {#sec011}
-----------

Our study demonstrates that dopamine modulates auditory midbrain processing of unexpected sensory input. We propose that dopamine release in the nonlemniscal IC encodes uncertainty by reducing the postsynaptic gain of PE signals, thereby dampening their drive over higher processing stages. The dopaminergic projections from the thalamic SPF to the IC could be the biological substrate of this early precision-weight mechanism. Thus, despite being usually neglected by most corticocentric approaches, our results confirm subcortical structures as a key player in PE minimization and perceptual inference, at least in the auditory system.

Materials and methods {#sec012}
=====================

Ethics statement {#sec013}
----------------

All methodological procedures were approved by the Bioethics Committee for Animal Care of the University of Salamanca (USAL-ID-195) and performed in compliance with the standards of the European Convention ETS 123, the European Union Directive 2010/63/EU, and the Spanish Royal Decree 53/2013 for the use of animals in scientific research.

Surgical procedures {#sec014}
-------------------

We conducted experiments on 31 female Long--Evans rats aged 9--17 weeks with body weights between 150 and 250 g. We first induced surgical anesthesia with a mixture of ketamine/xylazine (100 and 20 mg/kg respectively, intramuscular) and then maintained it with urethane (1.9 g/kg, intraperitoneal). To ensure a stable deep anesthetic level, we administered supplementary doses of urethane (approximately 0.5 g/kg, intraperitoneal) when the corneal or pedal withdrawal reflexes were present. We selected urethane over other anesthetic agents because it better preserves normal neural activity, having a modest, balanced effect on inhibitory and excitatory synapses \[[@pbio.3000744.ref093]--[@pbio.3000744.ref096]\].

Prior to the surgery, we recorded auditory brainstem responses (ABRs) with subcutaneous needle electrodes to verify the normal hearing of the rat. We acquired the ABRs using a RZ6 Multi I/O Processor (Tucker-Davis Technologies, TDT) and BioSig software (TDT) before beginning each experiment. ABR stimuli consisted of 0.1-millisecond clicks at a rate of 21 clicks/second, delivered monaurally to the right ear in 10-dB steps, from 10 to 90 decibels of sound pressure level (dB SPL), in a closed system through a speaker coupled to a small tube sealed in the ear.

After normal hearing was confirmed, we placed the rat in a stereotaxic frame in which the ear bars were replaced by hollow specula that accommodated the sound delivery system. We performed a craniotomy in the left parietal bone to expose the cerebral cortex overlying the left IC. We removed the dura overlying the left IC and covered the exposed cortex with 2% agar to prevent desiccation.

Data acquisition procedures {#sec015}
---------------------------

Experiments were performed inside a sound-insulated and electrically shielded chamber. All sound stimuli were generated using a RZ6 Multi I/O Processor (TDT) and custom software programmed with OpenEx suite (TDT, <https://www.tdt.com/component/openex-software-suite/>) and MATLAB (MathWorks, <https://www.mathworks.com/products/matlab.html>). In search of evoked auditory neuronal responses from the IC, we presented white noise bursts and sinusoidal pure tones of 75 milliseconds duration with 5-millisecond rise-fall ramps. Once the activity of an auditory unit was clearly identified, we only used pure tones to record the experimental stimulation protocols. All protocols ran at 4 stimuli per second and were delivered monaurally in a closed-field condition to the ear contralateral to the left IC through a speaker. We calibrated the speaker using a ¼-inch condenser microphone (model 4136, Brüel & Kjær) and a dynamic signal analyzer (Photon+, Brüel & Kjær) to ensure a flat spectrum up to approximately 73 dB SPL between 0.5 and 44 kHz and that the second and third signal harmonics were at least 40 dB lower than the fundamental at the loudest output level.

To record extracellular activity while carrying out microiontophoretic injections, we attached a 5-barrel glass pipette to a hand-manufactured, glass-coated tungsten microelectrode (impedance of 1.4--3.5 MΩ at 1 kHz), with the tip of the electrode protruding 15--25 μm from the pipette tip \[[@pbio.3000744.ref097]\]. We place the electrode over the exposed cortex, forming an angle of 20° with the horizontal plane toward the rostral direction. Using a piezoelectric micromanipulator (Sensapex), we advanced the electrode while measuring the penetration depth until we could observe a strong spiking activity synchronized with the train of searching stimuli.

Analog signals were digitized with a RZ6 Multi I/O Processor, a RA16PA Medusa Preamplifier, and a ZC16 headstage (TDT) at 12-kHz sampling rate and amplified 251×. Neurophysiological signals for multiunit activity were band-pass filtered between 0.5 and 4.5 kHz. Stimulus generation and neuronal response processing and visualization were controlled online with custom software created with the OpenEx suite (TDT) and MATLAB. A unilateral threshold for automatic action potential detection was manually set at about 2--3 standard deviations of the background noise. Spike waveforms were displayed on the screen and overlapped on each other in a pile-plot to facilitate isolation of units. Recorded spikes were considered to belong to a single unit when the SNR of the average waveform was larger than 5 (51% of the recorded units).

Stimulation protocols {#sec016}
---------------------

For all recorded neurons, we first computed the FRA, which is the map of response magnitude for each frequency/intensity combination ([Fig 2](#pbio.3000744.g002){ref-type="fig"}). The stimulation protocol to obtain the FRA consisted of a randomized sequence of sinusoidal pure tones ranging between 0.7 and 44 kHz, 75 milliseconds of duration with 5-millisecond rise-fall ramps, presented at a rate of 4 Hz, randomly varying frequency and intensity of the presented tones (3--5 repetitions of all tones).

### Protocol 1 {#sec017}

In a first round of experiments, we used the oddball paradigm ([Fig 5A](#pbio.3000744.g005){ref-type="fig"}) to study SSA. We presented trains of 400 stimuli containing 2 different frequencies (*f*~*1*~ and *f*~*2*~) in a pseudorandom order at a rate of 4 Hz and a level of 10--40 dB above threshold. Both frequencies were within the excitatory FRA previously determined for the neuron ([Fig 2](#pbio.3000744.g002){ref-type="fig"}) and evoked similar FRs. One frequency (*f*~*1*~) appeared with high probability within the sequence (STD; *p* = 0.9). The succession of STD tones was randomly interspersed with the second frequency (*f*~*2*~), presented with low probability within the sequence (DEV; *p* = 0.1). After obtaining 1 data set, the relative probabilities of the 2 stimuli were reversed, with *f*~*2*~ becoming the STD and *f*~*1*~ becoming the DEV ([Fig 5A](#pbio.3000744.g005){ref-type="fig"}). This allows to control for the physical characteristics of the sound in the evoked response, such that the differential response between DEV and STD of a given tone can only be due to their differential probability of appearance. The separation between *f*~*1*~ and *f*~*2*~ was 0.28 (49 units) or 0.5 (45 units; Protocol 2 was also applied to these units) octaves, which is within the range of frequency separations used in other previous studies \[[@pbio.3000744.ref045],[@pbio.3000744.ref046],[@pbio.3000744.ref060],[@pbio.3000744.ref064]--[@pbio.3000744.ref066],[@pbio.3000744.ref098],[@pbio.3000744.ref099]\]. The units from those 2 groups were pooled together, because their responses did not differ significantly. DEV and STD responses were averaged from all stimulus presentations from both tested frequencies.

The CSI was calculated as follows: $$CSI = \frac{{DEV}_{f1} + {DEV}_{f2} - {{STD}_{f1} - {STD}_{f2}}}{{{DEV}_{f1} + {DEV}_{f2}} + {{STD}_{f1} + {STD}_{f2}}}$$ where *DEV*~*fi*~ and *STD*~*fi*~ are FRs in response to a frequency *f*~*i*~ when it was presented in DEV and STD conditions, respectively. The CSI ranges between −1 and +1, being positive if the DEV response was greater than the STD response. The FRs in response to DEV or STD stimuli were calculated using windows of 100 milliseconds starting at the beginning of each stimulus. SFRs were calculated using windows of 75 milliseconds previous to each individual stimulus.

### Protocol 2 {#sec018}

In light of the recent discovery of PE signals recorded in the nonlemniscal IC \[[@pbio.3000744.ref045]\], we decided to adapt our stimulation protocol to that of Parras and colleagues for a second round of experiments, which incorporated the CAS \[[@pbio.3000744.ref061]\]. By arranging a set of 10 tones in a regular succession of ascending or descending frequency, no tone is ever immediately repeated. Consequently, whereas CAS does not induce SSA (as opposed to STD), its pattern remains predictable, so the next tone in the sequence can be expected (as opposed to DEV). Thus, this design contains 3 conditions of auditory transit: (1) no change or predictable repetition (i.e., STD), which is the most susceptible to SSA or repetition suppression ([Fig 5A](#pbio.3000744.g005){ref-type="fig"}, bottom); (2) predictable change (i.e., CAS; [Fig 5B](#pbio.3000744.g005){ref-type="fig"}); and (3) unpredictable change (i.e., DEV), which should allegedly elicit the strongest PE signaling when it surprisingly interrupts the uniform train of STDs ([Fig 5A](#pbio.3000744.g005){ref-type="fig"}, top).

Therefore, after computing the FRA ([Fig 2](#pbio.3000744.g002){ref-type="fig"}), we selected 10 evenly spaced tones at a fixed sound intensity 10--40 dB above minimal response threshold so that at least 2 tones fell within the FRA limits. Those 10 frequencies were separated from each other by 0.5 octaves, in order to make the results comparable to those of \[[@pbio.3000744.ref045]\]. We used the 10 tones to build the ascending and descending versions of CAS ([Fig 5B](#pbio.3000744.g005){ref-type="fig"}). We selected 2 tones within that lot to generate the ascending and descending versions of the oddball paradigm ([Fig 5A](#pbio.3000744.g005){ref-type="fig"}), comparing the resultant DEV with their corresponding CAS versions ([Fig 5B](#pbio.3000744.g005){ref-type="fig"}). All sequences were 400 tones in length, at the same, constant presentation rate of 4 Hz. Thus, each frequency could be compared with itself in DEV, STD, and CAS conditions ([Fig 5A and 5B](#pbio.3000744.g005){ref-type="fig"}), obtaining 40 trials per condition. To allow comparison between responses from different neurons, we normalized the spike count evoked by each tone in DEV, STD, and CAS as follows: $${DEV}_{N} = \frac{DEV}{N};\ {STD}_{N} = \frac{STD}{N};\ {CAS}_{N} = \frac{CAS}{N}$$ where $$N = \sqrt{{DEV}^{2} + {STD}^{2} + {CAS}^{2}}$$

From these normalized responses, we computed the iMM as: $$iMM = {DEV}_{N} - {STD}_{N}$$

These indices range between −1 and 1. The iMM is largely equivalent to the classic CSI as an index of SSA, as previously demonstrated by Parras and colleagues (see their S2 Fig in \[[@pbio.3000744.ref045]\]). Nevertheless, please beware the CSI provides 1 index for each pair of tones in the oddball paradigm, whereas the iMM provides 1 index for each tone tested.

Dopaminergic manipulation procedures {#sec019}
------------------------------------

After recording the chosen stimulation protocol in a "control condition," i.e., before any dopaminergic manipulation, we applied either dopamine or the D~2~-like receptor antagonist eticlopride (Sigma-Aldrich Spain) iontophoretically through multibarreled pipettes attached to the recording electrode. The glass pipette consisted of 5 barrels in an H configuration (World Precision Instruments, catalogue no. 5B120F-4) with the tip broken to a diameter of 30--40 μm \[[@pbio.3000744.ref097]\]. The center barrel was filled with saline for current compensation (165 mM NaCl). The others were filled with dopamine (500 mM) or eticlopride (25 mM). Each drug was dissolved in distilled water, and the acidity of the solution was adjusted with HCl (pH 3.5 for dopamine; pH 5 for eticlopride). The drugs were retained in the pipette with a current of −20 nA and ejected using currents of 90 nA (Neurophore BH-2 system, Harvard Apparatus). Thus, we released dopamine or eticlopride into the microdomain of the recorded neuron at concentrations that have been previously demonstrated effective in in vivo studies \[[@pbio.3000744.ref052]\]. About 5 minutes after the drug injection, we repeated the FRA and the chosen stimulation protocol continuously until the drug was washed away, leaving roughly 2--3 minutes between the end of one recording set and the beginning of the next one. The recording set showing a maximal SSA alteration relative to the control values was considered the "drug condition" of that neuron. We established the "recovery condition" when the CSI returned to levels that did not significantly differ from control values, never before 40 minutes postinjection. We used either dopamine or eticlopride during Protocol 1, whereas only dopamine was tested during Protocol 2.

Histological verification procedures {#sec020}
------------------------------------

At the end of each experiment, we inflicted electrolytic lesions (5 μA, 5 seconds) through the recording electrode. Animals were euthanized with a lethal dose of pentobarbital, after which they were decapitated, and the brains immediately immersed in a mixture of 1% paraformaldehyde and 1% glutaraldehyde in 1 M PBS. After fixation, tissue was cryoprotected in 30% sucrose and sectioned in the coronal plane at 40-μm thickness on a freezing microtome. We stained slices with 0.1% cresyl violet to facilitate identification of cytoarchitectural boundaries ([Fig 1](#pbio.3000744.g001){ref-type="fig"}). Finally, we assigned the recorded units to one of the main subdivisions of the IC using the standard sections from a rat brain atlas as reference \[[@pbio.3000744.ref100]\].

Data analysis {#sec021}
-------------

The peristimulus histograms representing the time-course of the responses (Figs [3E](#pbio.3000744.g003){ref-type="fig"}, [3F](#pbio.3000744.g003){ref-type="fig"}, [4E and 4F](#pbio.3000744.g004){ref-type="fig"}) were calculated using 1-millisecond bins and then smoothed with a 6-millisecond gaussian kernel ("ksdensity" function in MATLAB) to estimate the spike-density function over time.

All the data analyses were performed with SigmaPlot (Systat Software, <https://systatsoftware.com/products/sigmaplot/>) and MATLAB software, using the built-in functions, the Statistics and Machine Learning toolbox for MATLAB, and custom scripts and functions developed in our laboratory. Unless stated otherwise, all average values for trials and neurons in the present study are expressed as "median (interquartile range)," because the data did not follow a normal distribution (1-sample Kolmogorov-Smirnov test).

We performed a bootstrap procedure to analyze dopaminergic effects on each individual neuron. SSA indices, both CSI \[[@pbio.3000744.ref040]\] and iMM \[[@pbio.3000744.ref045]\], are calculated from the averages of the single-trial responses to DEV, STD, and CAS. Consequently, only 1 value of such indices can be obtained for each unit and condition. Therefore, to test the drug effects on each unit, we calculated the 95% bootstrap confidence intervals for the SSA index in the control condition. The bootstrap procedure draws random samples (with replacement) from the spike counts evoked on each trial, separately for DEV and STD stimuli, and then applies either the CSI or the iMM formula. This procedure is repeated 10,000 times, thus obtaining a distribution of expected CSI values based on the actual responses from a single recording. We applied this procedure using the bootci MATLAB function, as in previous studies of SSA neuromodulation in the IC \[[@pbio.3000744.ref062],[@pbio.3000744.ref064]--[@pbio.3000744.ref066]\], which returned the 95% confidence interval for the CSI in the control condition. We considered drug effects to be significant when SSA index in the drug condition did not overlap with the confidence interval in the control condition.

We used the Wilcoxon signed rank test (signrank function in MATLAB) to check for differences at the population level between the control and drug CSI and FRs.

Supporting information {#sec022}
======================
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To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <https://journals.plos.org/plosbiology/s/submission-guidelines#loc-materials-and-methods>

Thank you again for your submission to our journal. We hope that our editorial process has been constructive thus far, and we welcome your feedback at any time. Please don\'t hesitate to contact us if you have any questions or comments.

Best wishes,

Roli

Roland G Roberts, PhD,

Senior Editor

PLOS Biology

\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*

REVIEWERS\' COMMENTS:

Reviewer \#1:

The Authors present the results of single-neuron recordings in the inferior colliculi of anaesthetised mice (N=31), combining auditory oddball paradigms with microiontophoretic application of dopamine or eticlopride. They observe differential effects of dopamine on responses to auditory deviants, standards, and control sounds. These effects are heterogeneous across neurons but at the population level decrease the amplitude of deviant responses. The findings are interpreted within the predictive coding framework as negative precision modulation.

Overall the manuscript is very clearly written and reports novel findings regarding dopaminergic effects on stimulus-specific adaptation. However, the interpretation of the results is less clear, given the heterogeneity of results across neurons and some methodological decisions.

Major comments:

1\. Rationale: While dopaminergic gain modulation is ubiquitous in cortical and subcortical regions, its role in sensory prediction error signalling is not as obvious as implied by this manuscript. All references cited by the Authors in the introduction (line 123) and discussion (line 629) concern dopaminergic effects on reward prediction errors, not sensory prediction errors. The neural implementation of reward and sensory prediction error signalling may be quite different: for instance, reward prediction errors may be signed (positive or negative; Keller & Mrsic-Flogel, 2018), while sensory prediction errors have been suggested to be unsigned (Bastos et al., 2012). In the sensory prediction error literature, cholinergic or NMDA-ergic effects are more often reported (Moran et al., 2013; Rosch et al., 2019; Auksztulewicz et al., 2018) and dopaminergic manipulations much less common (Todd et al., 2013). Within the predictive coding framework, classical neuromodulators are often thought to increase the precision of prediction error signalling (Moran et al., 2013), contrary to the inhibitory net effects described in this manuscript; dissociations between dopaminergic and cholinergic signalling have also been proposed (Marshall et al., 2016). Taken together, the manuscript would benefit from a more comprehensive discussion of how the current results fit into the other studies on neuromodulatory effects on SSA / mismatch responses (including Authors' own work, e.g. Ayala & Malmierca, 2015) and the broader theoretical framework.

2\. Interpretation: Albeit the net effects (averaged across neurons) show reduced responses to deviants in both protocols (lines 414 and 522), the results are very heterogeneous across units. In protocol 1 (classical oddball), a similar proportion of neurons show decreased and increased CSI (39 vs. 30 respectively) following dopamine application; in protocol 2 (oddball + cascade), the numbers are not reported in text but Figure 6 suggests considerable variability across units. Nevertheless, the Authors conclude that dopamine reduces prediction error signalling, possibly due to reduced precision (as understood in the predictive coding framework). However, on grounds of the predictive coding framework, at least in the cortex, specific hypotheses have been formulated regarding (1) the laminar specificity of prediction error signalling (supragranular layers); (2) the class of neurons encoding gain modulation (pyramidal cells). It is unclear whether or how other types of neurons (e.g. inhibitory interneurons) signal sensory prediction errors and how they might be regulated by neuromodulatory gain control. As such, the study has a potential in identifying previously unknown specific effects of dopamine on sensory prediction error signalling in the IC; however, to this end, variability across neurons should be analysed with respect to the types of cells involved (putative pyramidal cells vs. inhibitory interneurons). One possibility is that the neurons showing increased CSI might be predominantly labelled as putative pyramidal cells, while neurons showing decreased CSI might be labelled as putative inhibitory interneurons. Therefore, I would recommend performing a spike shape analysis to classify cells into these two broad categories, and testing for any differences in CSI effects between these classes.

3\. Analysis: The Authors report baseline shifts in protocol 1 (Results, lines 427-436) in addition to effects on baseline-corrected measures. The reported baseline shifts are in line with previous proposals that precision modulation should be visible in the pre-stimulus baseline (Hesselmann et al., 2010). However, how might such robust effects of dopamine on spontaneous activity (+61% and -50% in neurons showing decreased vs. increased CSI) affect the analysis of baseline-corrected data? For instance, is the lack of a significant effect on DEV responses (p = 0.114; line 430) due to a ceiling effect given a strong increase in spontaneous firing? More generally, if I understand correctly, the baseline seems to be simply subtracted per condition from the spike-density function of each neuron (lines 298 onwards); as a result, the reported effects on evoked responses may to some extent depend on the baseline effects. Let's consider the following scenario (based on Fig. 3E):

\- The baseline-corrected spike density peak for DEV is 40 spikes/s in the control condition and 30 spikes/s following dopamine (Fig. 3E). At the same time, there is a baseline firing shift of ca. +60% (line 431)

\- A neuron with very sparse spontaneous firing in the control condition (e.g. 3 spikes/s) would accordingly peak at 43 spikes/s without baseline correction; after dopamine, the increased baseline would be 4.8 spikes/s (60% more than 3 spikes/s) and the peak response at 34.8 spikes/s. Therefore, in absolute terms, this neuron would reduce its activity following dopamine

\- Another neuron with very fast spontaneous firing in the control condition (e.g. 40 spikes/s) would peak at 80 spikes/s without baseline correction; after dopamine, the increased baseline would be 64 spikes/s and the peak response 94 spikes/s. Therefore, in absolute terms, this neuron would actually increase its activity following dopamine.

The Authors should consider whether and how their effects might be affected by baseline correction methods, and whether other correction methods (e.g. division or log-normalisation) wouldn't be more desirable. For completeness, could the Authors also report the baseline effects following eticlopride administration as well as dopamine in protocol 2?

Minor comments:

\- Abstract, line 33: I would suggest rephrasing as "... 'precision', which is theoretically encoded by the neuromodulatory (e.g., dopaminergic) systems"

\- Introduction, lines 92-93: I would suggest rephrasing as "A neurobiologically informed theory of hierarchical perceptual inference, known as predictive coding..."

\- Lines 105-107: While a separation of mismatch responses into the prediction error and repetition suppression components based on responses to deviants and standards (vs. controls) is advocated here by the Authors, other accounts (e.g. Garrido et al., 2010; Auksztulewicz & Friston, 2015) have suggested that the difference between deviance detection and adaptation may rather be linked to differences in mechanisms (connectivity vs. gain) or time scales (inference vs. learning)

\- Methods, line 205: which frequency range was used in the FRA recordings and subsequent experiments?

\- Line 251: Please reiterate that analyses are based on 40 trials per condition in this protocol

\- Line 295: Please clarify whether SEMs are across trials, neurons, or both

\- Line 299: What was the bin size for PSTH calculation before smoothing? How was the optimal bin size determined?

\- Line 307: Were only excitatory responses considered? If so, what were the criteria for excluding inhibitory responses, and how could this influence the results? For instance, could it be the case that some neurons show an overall sensory inhibition relative to baseline in the control condition, but a release from inhibition following dopamine administration?

\- Line 331: "a different neuronal response to DEV and CAS could only be due to the fact that DEV violates a prediction of the perceptual model whereas CAS fulfils it" -- isn't this only true under the assumption that only the immediately preceding stimulus influences the neural response? Cascades and oddball sequences are only matched with respect to one preceding stimulus.

\- Lines 387-389: From this section it is not clear what kind of a follow-up analysis is conducted on these neurons, and whether it constitutes a form of double-dipping.

\- Lines 390-392: From this section it is not clear that the regression analysis is done across neurons and which variables are treated as predictors

\- Results, line 419: Previously in the methods section FRA has only been described as an initial mapping, not as a repeated measurement

\- Lines 444-446: Were the effects of dopamine continuously assessed?

\- Line 459: Was there enough statistical power, based on 8 or 15 units, to test for statistical significance?

\- Line 491: The analysis of first spike latency is not described in the methods and it is unclear why it is reported in this section but not in the other analyses

\- Line 518: Please provide numbers of neurons showing increases, decreases, and stable responses

\- Discussion, lines 568-570: These effects were reported as not significant in the results section

\- Lines 574: The statistical analysis supporting this statement was not reported in the results section

\- Lines 604-606 and 610: Fig. 6C suggests that many neurons also have negative mismatch index (iMM); furthermore, dopamine application brings the prediction error index (iPE) to negative values. The Authors should discuss these findings in more detail, as they go beyond the standard understanding of sensory prediction errors within the predictive coding framework.

\- Lines 630-636: This paragraph summarises the results in terms of negative precision modulation, focusing on the net effects (but not on heterogeneity of effects across neurons). However, it does not contextualise these findings in terms of predictions of most theoretical accounts of hierarchical perceptual inference or other neuromodulatory effects reported in the IC (see major point 1). I would suggest to expand the discussion on these topics, as it would enhance the impact of the paper as a contribution to revising the predictive coding framework.

\- Figures 3C and 4C: please mark statistical significance (or lack thereof) on the plots

\- Figure 5C: please clarify whether error bars are across the 5 neurons only

Typos / grammar:

\- Line 150: "processed"

\- Line 170: "stimuli"?

\- Line 237: "- as opposed to DEV."

\- Line 273: "tested during / in"

\- Line 273: "in a few cases"?

\- Line 331: "could only be due to the fact"

\- Line 580: "in the IC cortices, but..."

\- Line 645: "extent"
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Reviewer \#2:

This manuscript describes the effect of Dopamine release on the response magnitude of unpredictable but not predictable stimulus events. The results are discussed in the framework of the propagation of prediction errors from the midbrain to higher stations and suggests a gating-role of Dopamine activity.

A stimulus-specific adaption (SSA) paradigm was used, i.e., presenting a tone sequence containing predictable (high probability; standard) tones and, intermixed, some unpredictable (low probability; deviant) tones of a slightly different frequency than the standard. The authors show that the usual significant increase in response magnitude to deviants is reduced in the presence of dopamine in the cortex of the inferior colliculus. By contrast, the responsiveness to the standard tones is only minimally affected by the presence of dopamine. The experimental findings appear solid and the approach is based on detailed previous studies, many by the current authors, with a set of reasonable controls.

The main issue with the manuscript is the sole interpretation of the findings in a framework of predictive coding theory. While it is not unreasonable to cast the main hypotheses in such a scheme, it is not helpful to omit potential consequences or other potential interpretations since Dopamine release has been postulated to participate in a number of subcortical and cortical functions. Dopamine neurons have been shown to be activated by new stimuli or unpredicted rewards and reporting an error in the prediction of reward during learning. They also play a role in long-term potentiation, a putative cellular mechanism underlying plasticity, and in controlling membrane potential states. The proposed role of dopamine in modulating or even gating propagation of prediction error signals from the IC to higher stations seems worthwhile, yet a number of related aspects remain unclear. For example it is not made clear how error encoding "precision" is related to changes in response magnitude to the deviant (the implicit assumption that firing follows a strike poisson rule is not necessarily valid). Furthermore, the Dopamine is experimentally released minutes before the stimulus sequence, thus it is not related in time to a singular deviant event but is more akin to a local state-change as in a naturally slow release of Dopamine due to unknown causes. These aspects would make a more thorough discussion of the findings worthwhile for the reader.

In the following are a number of questions/points that would be useful to address.

Line 95: "....explains predictable inputs away." To understand this phrase requires a thorough knowledge of predictive coding theory. Of course the stimulus-based information -- in addition to the expectation/predictability information -- is still present.

Line 97: "superior ... levels". Should be 'proximal' or 'higher'

Line 116: unclear meaning of sentence: "....to adjust the relative influence of prediction error signals over perception". Perception is not unequivocally tied to stimulus or error representation.

Line 120: unclear meaning - reformulate: "regulates forward message-passing modulating the postsynaptic gain"

Line 127: perhaps "...modulates response properties and possibly predictive auditory processing aspects".

Lone 129: "perhaps: "....IC cortices, compatible with the notion of lowering the precision of prediction signals". But see comment above about magnitude strength and variance.

Line 224: What are potential consequence for using 0.28 octave spacing in Protocol 1 and 0.5 oct in Protocol 2?

Line 233: rewrite "... a bunch of tones..."; too colloquial

Line 554: the word "gating" usually implies an all-or-nothing mechanisms.

Line 604: State the reason why you conclude this (because CAS responses were not affected....)

Line 615: One could add here that the differential effect of Dopamine on DEV and STD can not be explained by differences in the initial firing rate for DEV and STD because CAS has also a relatively high firing rate and seem unaffected.

Lines 630 to 636: largely speculative and not very crisp. Especially the last line "....deeming their 'reliability'....." is very opaque.

Reviewer \#3:

This is a nice manuscript that looks at the role of dopamine and how it modulates stimulus specific adaption at the level of the auditory midbrain. The authors show that dopamine signaling modulates SSA in the IC cortices and that this signaling is highly correlated with and consistent with a prediction error signal (top down modulation). Below I provide comments / suggestions, particularly with details that need clarification or could be improved for correctness.

1\) The authors performed histological verification with lesions to verify that they are in cortical regions of IC. It would be highly valuable to know where exactly in the IC cortices these recordings are situated. Are the recordings in dorsal cortex, lateral cortex etc? Can the authors collapse their location information on a standardized atlas of IC? And are there differences in location between sites that exhibit significant changes with dopamine / or antagonist? I realize that a full mapping of these functional properties may be a bit beyond the scope if this initial manuscript, having slightly more detailed anatomical information as it relates to the functional properties would be valuable nonetheless.

2\) Line 33 and 44 -- abstract -- can the authors more concisely define their usage of "precision" or alternately use a more suitable description. Its not obvious how being accurate (precise) is the relevant factor in this study. What seems to be most important is simply the fact that dopaminergic system modulates neural response in a manner the mimics prediction error signaling. This is precisely what the study shows. As far as I can tell, I don't really see anything in the manuscript regarding precision, since the authors are not using any measures that quantify how accurate the signaling really is.

3\) Line 196 -- "spike waveforms are identical and clearly separable from other smaller units and the background noise ..."

First, the waveforms may very well be very consistent and similar across spike but there is no way that they can be identical!

Have the authors quantified the waveform quality? And did you use a quantitative selection criteria other than visual inspection (not ideal) to designate single units? For example, one can compute the signal-to-noise ratio (or a multitude of other quality metrics) of the spike waveforms and can designate single units as those waveforms that meet a specific criteria (for instance SNR\>5).

At minimum, it would be valuable if the authors compute a metric such as SNR for all the units and provide some statistics for the quality of their waveforms.

4\) Line 235 and several other locations in the MS -- "in consequence" -- better to use "Consequently"

5\) Line 233 -- "bunch of tones", maybe better to say a "set of 10 tones" or "sequence of 10 tones".

6\) Line 266 -- "microdomaine" -- Is there any information the authors can provide or can you estimate the radius of these microdomains? Or even the volume of the drug delivered? It would be valuable to know the spatial extent over which the antagonist affects the IC neural circuitry.

Also, in this regard, can the authors speak towards whether the volume injection size correlates with whether a significant effect is observed or not? Im not sure this is even possible to do, but if it were it would be interesting to know.

7\) Line 315 -- CSI metric -- If one were to compute a CSI for each sound (CSI_1, CSI_2) how does this traditional CSI compare? Is it generally correlated with both? Or does generally one or the other sound dominate?

8\) Line 382 -- bootstrap procedure -- a bit more detail on exactly how this is done would be useful. Are you bootstrapping across trials? By requiring that the 95% confidence intervals don't overlap, is this equivalent to a significance criteria of p\<0.05?

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

10.1371/journal.pbio.3000744.r003
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Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

24 Apr 2020

Dear Manolo,

Thank you for submitting your revised Research Article entitled \"Dopamine modulates prediction error forwarding in the nonlemniscal inferior colliculus\" for publication in PLOS Biology. I have now obtained advice from two of the original reviewers and have discussed their comments with the Academic Editor.

Based on the reviews, we will probably accept this manuscript for publication, assuming that you will modify the manuscript to address the remaining points raised by the reviewers and the additional comments from the Academic Editor. Please also make sure to address the data and other policy-related requests noted at the end of this email.

IMPORTANT:

a\) Please address the remaining requests from the reviewers.

b\) Please address the request from the Academic Editor to make the implications of your findings more accessible to the broad readership of PLOS Biology. This is crucial.

c\) \...and please feed this clarity and accessibility through to the title. At the moment, non-neuroscientists will not realise that (while your paper may have wider implications) the focus on the IC means that your study is about the auditory modality. Also they may not appreciate that \"prediction error\" is more interesting than it sounds. Any improvement to the clarity/accessibility of the title would be appreciated.

d\) Please attend to my Data Policy requests below. Your current Data Availability Statement says \"data details are available from the authors upon reasonable request\" - this is not compatible with PLOS policy.

We expect to receive your revised manuscript within two weeks. Your revisions should address the specific points made by each reviewer. In addition to the remaining revisions and before we will be able to formally accept your manuscript and consider it \"in press\", we also need to ensure that your article conforms to our guidelines. A member of our team will be in touch shortly with a set of requests. As we can\'t proceed until these requirements are met, your swift response will help prevent delays to publication.

\*Copyediting\*

Upon acceptance of your article, your final files will be copyedited and typeset into the final PDF. While you will have an opportunity to review these files as proofs, PLOS will only permit corrections to spelling or significant scientific errors. Therefore, please take this final revision time to assess and make any remaining major changes to your manuscript.

NOTE: If Supporting Information files are included with your article, note that these are not copyedited and will be published as they are submitted. Please ensure that these files are legible and of high quality (at least 300 dpi) in an easily accessible file format. For this reason, please be aware that any references listed in an SI file will not be indexed. For more information, see our Supporting Information guidelines:

<https://journals.plos.org/plosbiology/s/supporting-information>

\*Published Peer Review History\*

Please note that you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

<https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/>

\*Early Version\*

Please note that an uncorrected proof of your manuscript will be published online ahead of the final version, unless you opted out when submitting your manuscript. If, for any reason, you do not want an earlier version of your manuscript published online, uncheck the box. Should you, your institution\'s press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us as soon as possible if you or your institution is planning to press release the article.

\*Protocols deposition\*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <https://journals.plos.org/plosbiology/s/submission-guidelines#loc-materials-and-methods>

\*Submitting Your Revision\*

To submit your revision, please go to <https://www.editorialmanager.com/pbiology/> and log in as an Author. Click the link labelled \'Submissions Needing Revision\' to find your submission record. Your revised submission must include a cover letter, a Response to Reviewers file that provides a detailed response to the reviewers\' comments (if applicable), and a track-changes file indicating any changes that you have made to the manuscript.

Please do not hesitate to contact me should you have any questions.

Best wishes,

Roli

Roland G Roberts, PhD,

Senior Editor

PLOS Biology

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

ETHICS STATEMENT:

\-- Please include the full name of the IACUC/ethics committee that reviewed and approved the animal care and use protocol/permit/project license. Please also include an approval number.

\-- Please include the specific national or international regulations/guidelines to which your animal care and use protocol adhered. Please note that institutional or accreditation organization guidelines (such as AAALAC) do not meet this requirement.

\-- Please include information about the form of consent (written/oral) given for research involving human participants. All research involving human participants must have been approved by the authors\' Institutional Review Board (IRB) or an equivalent committee, and all clinical investigation must have been conducted according to the principles expressed in the Declaration of Helsinki.

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

DATA POLICY:

You may be aware of the PLOS Data Policy, which requires that all data be made available without restriction: <http://journals.plos.org/plosbiology/s/data-availability>. For more information, please also see this editorial: <http://dx.doi.org/10.1371/journal.pbio.1001797>

Note that we do not require all raw data. Rather, we ask that all individual quantitative observations that underlie the data summarized in the figures and results of your paper be made available in one of the following forms:

1\) Supplementary files (e.g., excel). Please ensure that all data files are uploaded as \'Supporting Information\' and are invariably referred to (in the manuscript, figure legends, and the Description field when uploading your files) using the following format verbatim: S1 Data, S2 Data, etc. Multiple panels of a single or even several figures can be included as multiple sheets in one excel file that is saved using exactly the following convention: S1_Data.xlsx (using an underscore).

2\) Deposition in a publicly available repository. Please also provide the accession code or a reviewer link so that we may view your data before publication.

Regardless of the method selected, please ensure that you provide the individual numerical values that underlie the summary data displayed in the following figure panels as they are essential for readers to assess your analysis and to reproduce it: Figs 1, 2, 3, 4. NOTE: the numerical data provided should include all replicates AND the way in which the plotted mean and errors were derived (it should not present only the mean/average values).

Please also ensure that figure legends in your manuscript include information on where the underlying data can be found, and ensure your supplemental data file/s has a legend.

Please ensure that your Data Statement in the submission system accurately describes where your data can be found.

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

REVIEWERS\' COMMENTS:

Reviewer \#1:

Following revisions, the manuscript has improved considerably. I only have a few minor comments:

\- In the discussion (lines 530-538), the Authors interpret their finding in terms of dopaminergic signalling of \"imprecision\" via net negative gain. This seems to be the main interpretation of their results, with major implications for predictive coding theories. However, it is unclear how such net negative gain could be signalled. Could the Authors speculate on a plausible neuroanatomical circuit mediating net negative gain, for example in terms of inhibitory and disinhibitory circuits in nonlemniscal thalamus (Chen et al., JNeurosci 2018, doi: 10.1523/JNEUROSCI.2173-17.2018)?

\- In the introduction, the term \"negative gain\" (line 139) should be clarified

\- I would suggest foreshadowing the discussion of sensory vs. reward prediction errors in the introduction so that the reader has a more informed impression of the literature

Reviewer \#3:

The authors have adequately addressed all of my comments. Insofar as my first point regarding histological verification, I think it\'s worthwhile including the histological/lesion picture as supplement material and I encourage the authors to do so. Otherwise, I am fully satisfied with all other aspects of the study. Great Job!

COMMENTS FROM THE ACADEMIC EDITOR:

I'm not quite sure they have done the necessary work yet to broaden the appeal for the broader target readership of the journal. I think they owe a paragraph at the beginning, and probably more text later on, that provides context where the mechanisms that they are identifying are of broader significance and interest.
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, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

3 Jun 2020

Dear Dr Malmierca,

On behalf of my colleagues and the Academic Editor, David Poeppel, I am pleased to inform you that we will be delighted to publish your Research Article in PLOS Biology.

The files will now enter our production system. You will receive a copyedited version of the manuscript, along with your figures for a final review. You will be given two business days to review and approve the copyedit. Then, within a week, you will receive a PDF proof of your typeset article. You will have two days to review the PDF and make any final corrections. If there is a chance that you\'ll be unavailable during the copy editing/proof review period, please provide us with contact details of one of the other authors whom you nominate to handle these stages on your behalf. This will ensure that any requested corrections reach the production department in time for publication.

Early Version

The version of your manuscript submitted at the copyedit stage will be posted online ahead of the final proof version, unless you have already opted out of the process. The date of the early version will be your article\'s publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

PRESS

We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with <biologypress@plos.org>. If you have not yet opted out of the early version process, we ask that you notify us immediately of any press plans so that we may do so on your behalf.

We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit <http://www.plos.org/about/media-inquiries/embargo-policy/>.

Thank you again for submitting your manuscript to PLOS Biology and for your support of Open Access publishing. Please do not hesitate to contact me if I can provide any assistance during the production process.

Kind regards,

Alice Musson

Publishing Editor,

PLOS Biology

on behalf of

Roland Roberts,

Senior Editor

PLOS Biology

[^1]: I have read the journal\'s policy and the authors of this manuscript have the following competing interests: MSM is an Academic Editor and a member of editorial board of PLOS Medicine.
